June 28, 2017

Researchers Identify CXCR4 as Weak Therapeutic Target for Pleural Mesothelioma

CXCR4 is highly produced in more than 20 tumor types, promoting tumor growth and progression, tumor invasiveness, and metastasis. That is what studies in lab-grown cells have shown. But a novel PET/CT imaging agent targeting CXCR4 in cancer mouse models and patients has shown otherwise. {read more here}